Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Mersana Therapeutics Inc (NQ: MRSN )

3.370 UNCHANGED
Streaming Delayed Price Updated: 10:03 AM EDT, May 2, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Mersana Therapeutics Inc

< Previous 1 2 3 4 5 Next >
Why Teledyne Technologies Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
The Analyst Verdict: Mersana Therapeutics In The Eyes Of 5 Experts
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
Expert Outlook: Mersana Therapeutics Through The Eyes Of 5 Analysts
Via Benzinga
A Preview Of Mersana Therapeutics's Earnings
Via Benzinga
What To Know About Citigroup's Upgrade of Mersana Therapeutics
Via Benzinga
Why Butterfly Network Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Shares of Butterfly Network, Inc. (NASDAQ: BFLY) fell sharply during Thursday’s session after the company reported mixed fourth-quarter financial results. 
Via Benzinga
Hormel Foods Reports Upbeat Earnings, Joins Pure Storage, Okta, Papa John's International And Other Big Stocks Moving Higher On Thursday
U.S. stocks were higher, with the Nasdaq Composite gaining around 50 points on Thursday. 
Via Benzinga
Topics Stocks
Exposures US Equities
A Preview Of Mersana Therapeutics's Earnings
Via Benzinga
3 Biotech Stocks to Turn $10,000 Into $1 Million: January 2024
Biotech stocks are some of the most exciting opportunities on the market. Find the right ones with catalysts, and you could make a fortune. 
Via InvestorPlace
Why KeyCorp Shares Are Trading Lower By Over 5%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Shares of KeyCorp (NYSE: KEY) moved lower during Thursday’s session after the company reported fourth-quarter financial results. Revenues of $1.538 billion, down 19.0% Y/Y, slightly topped the... 
Via Benzinga
How To Invest In The Healthcare Sector
If things go wrong with some healthcare companies, investors often justify why they stay in the stock. And when things go right, they can go right in a hurry. Mersana Therapeutics is an example of how... 
Via Talk Markets
Why Mersana Therapeutics Stock Is Plunging Today?
Mersana Therapeutics Inc (NASDAQ: MRSN) shares are sinking after the company announced that the UPLIFT clinical trial of upifitamab rilsodotin (UpRi) did  
Via Benzinga
What 4 Analyst Ratings Have To Say About Mersana Therapeutics
Via Benzinga
Why Avantor Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Gainers Unique Fabricating, Inc. (NYSE: UFAB) shares jumped 113% to $0.4605 after gaining 12% on Thursday. 
Via Benzinga
Dow Dips Over 200 Points; McDonald's Tops Q2 Expectations
U.S. stocks turned lower toward the end of trading on Thursday, with the Dow Jones falling more than 200 points . The Dow traded down 0.59% to 35,310.03 while the NASDAQ fell 0.44% to 14,064.61. The... 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 28, 2023
Via Benzinga
Stocks That Hit 52-Week Lows On Thursday
  During Thursday, 56 stocks hit new 52-week lows. 
Via Benzinga
Why Willis Towers Watson Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Gainers Femasys Inc. (NASDAQ: FEMY) gained 54% to $0.55. Femasys reported a notice of allowance for new U.S. patent application covering use of FemBloc for female permanent birth control. 
Via Benzinga
Nasdaq Up 1%; Meta Shares Surge Following Upbeat Results
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining around 1% on Thursday. Following the market opening Thursday, the Dow traded up 0.15% to 35,573.49 while the NASDAQ... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 27, 2023
Via Benzinga
Dow Jumps 100 Points; US GDP Rises 2.4% In Q2
U.S. stocks traded higher this morning, following the release of major economic reports on Thursday. Following the market opening Thursday, the Dow traded up 0.28% to 35,620.79 while the NASDAQ rose... 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Cancer Drug Trials Put On Hold After Patients Died
Recent reports from two drug companies that had been conducing separate clinical trials to evaluate cancer treatments reveal that the trials were halted due to the deaths of six participants, including... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 16, 2023
Via Benzinga
NVIDIA To Rally Over 17%? Here Are 10 Other Analyst Forecasts For Friday
Raymond James boosted the price target for Jabil Inc. (NYSE: JBL) from $100 to $120. Raymond James analyst Melissa Fairbanks maintained a Strong Buy rating. Jabil shares rose 5% to close at $104.64 on... 
Via Benzinga
Crude Oil Rises Sharply; Jabil Posts Upbeat Q3 Results
U.S. stocks traded higher toward the end of trading, with Dow Jones gaining around 450 points on Thursday. The Dow traded up 1.32% to 34,429.39 while the NASDAQ rose 1.27% to 13,799.28. The S&P 500,... 
Via Benzinga
Mersana's UpRi Shows Potential in Ovarian Cancer; Analyst Initiates Coverage with Buy Rating
Guggenheim Partners has initiated coverage on Mersana Therapeutics Inc (NASDAQ: MRSN) with a Buy rating  
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
< Previous 1 2 3 4 5 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.